Kevin Koch Edgewise Therapeutics, Inc. (EWTX) insider trading activity
Kevin Koch is President and CEO of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 20,619 shares of EWTX, which is worth approximately $260,005. The most recent transaction as insider was on May 02, 2025, when has been sold 4,276 shares (Common Stock) at a price of $16.45 per share, resulting in proceeds of $70,340. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
20.6K
42.42%
3M change
42.42%
12M change
Total Value Held
$260,005
KEVIN KOCH Transaction History
KK
Kevin Koch
President and CEO
Boulder, CO